The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many pharmaceutical companies have promised to build.

A new program to boost U.S. drug manufacturing with streamlined processes, regulatory support. Read more here.

The U.S. Food and Drug Administration announced Thursday it is launching "FDA PreCheck" in order to help construct drug ...

The U.S. Food and Drug Administration on Thursday announced a new program to speed up construction and review of drug ...

Improving how the FDA disseminates already-public information about approved drugs may be unsexy, but it would be a big step ...

The FDA accepted a resubmitted new drug application for reproxalap, a first-in-class investigational topical therapy for dry eye disease, according to a press release from Aldeyra Therapeutics ...

Juul's main competitors, Vuse and Njoy, each previously received FDA permission to remain on the market. Njoy sells the only other menthol-flavored e-cigarettes authorized by FDA.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for topical ...

Juul's main competitors, Vuse and Njoy, each previously received FDA permission to remain on the market. Njoy sells the only other menthol-flavored e-cigarettes authorized by FDA.

GUANGZHOU, China, July 16, 2025 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars ...

Spectral AI, Inc. (NASDAQ:MDAI) is one of the most popular AI penny stocks to buy according to billionaires. On June 30, Spectral AI (NASDAQ:MDAI) submitted a De Novo 510k application to the FDA ...